A candidate set of 141 sarcoma-relevant genes (S1 Table), identified by transcriptional profiling of genetically engineered mouse RMS and non-myogenic sarcomas driven by KRAS(G12v) and CDKN2A deletion, was previously published [6]. This evidence concerns the gene KRAS and sarcoma.